Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene/Benzoyl Peroxide Gel in Acne Vulgaris
NCT00421993Phase 3Completed
- Sponsor
- Galderma
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of adapalene and benzoyl peroxide + sulfur in acne vulgaris (4 arms), sponsored by Galderma. Primary endpoints: Success Rate on the Investigator's Global Assessment at 12 weeks, Changes in Inflammatory Lesion Counts at 12 weeks and 1 more. Started Oct 2006; status: completed.
02
Drugs
adapalenebenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00421993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421993.